[EN] (CONDENSED) PYRIMIDONE AND (CONDENSED) PYRIDONE COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM [FR] NOUVEAUX COMPOSES
[EN] TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS<br/>[FR] COMPOSÉS TRICYCLIQUES UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2016183118A1
公开(公告)日:2016-11-17
The present invention is directed to tricyclic compounds of the formula (I), wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**
作者:Nima Rajabi、Tobias N. Hansen、Alexander L. Nielsen、Huy T. Nguyen、Michael Bæk、Julie. E. Bolding、Oskar Ø. Bahlke、Sylvester E. G. Petersen、Christian R. O. Bartling、Kristian Strømgaard、Christian A. Olsen
DOI:10.1002/anie.202115805
日期:2022.5.23
A SAR study of mechanism-based inhibitors of the sirtuin 5 (SIRT5) hydrolase, containing isosteres of an essential carboxylic acid moiety, furnished heterocycles with excellent potency and slow, tight-binding kinetics against the enzyme. Evaluation of selected compounds in cells revealed that transient masking of the heterocycle provided improved inhibitors with a high level of target engagement in
一项基于机制的 sirtuin 5 (SIRT5) 水解酶抑制剂的 SAR 研究,包含必需羧酸部分的等排体,为杂环提供了优异的效力和对酶的缓慢、紧密结合的动力学。对细胞中选定化合物的评估表明,杂环的瞬时掩蔽提供了改进的抑制剂,在培养的细胞中具有高水平的靶标参与。
[EN] 2-(AMINO-SUBSTITUTED)-4-ARYL PYRAMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES<br/>[FR] 2-(AMINO-SUBSTITUEES)-4-ARYL PYRAMIDINES ET COMPOSES ASSOCIES UTILES DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES
申请人:MILLENNIUM PHARM INC
公开号:WO2005066139A3
公开(公告)日:2005-10-13
Jayachandra Reddy; Somasekhara Reddy, Asian Journal of Chemistry, 2010, vol. 22, # 7, p. 5165 - 5174